Review and evolution of guidelines for diagnosis of COVID-19 vaccine induced thrombotic thrombocytopenia (VITT)
Coronavirus disease 2019 (COVID-19) is a life-threatening infectious disease caused by Severe acute respiratory syndrome Coronavirus-2 (SARS-CoV-2). In response to the still ongoing pandemic outbreak, a number of COVID-19 vaccines have been quickly developed and deployed. Although minor adverse even...
Uložené v:
| Vydané v: | Clinical chemistry and laboratory medicine Ročník 60; číslo 1; s. 7 |
|---|---|
| Hlavní autori: | , , |
| Médium: | Journal Article |
| Jazyk: | English |
| Vydavateľské údaje: |
Germany
01.01.2022
|
| Predmet: | |
| ISSN: | 1437-4331, 1437-4331 |
| On-line prístup: | Zistit podrobnosti o prístupe |
| Tagy: |
Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
|
| Abstract | Coronavirus disease 2019 (COVID-19) is a life-threatening infectious disease caused by Severe acute respiratory syndrome Coronavirus-2 (SARS-CoV-2). In response to the still ongoing pandemic outbreak, a number of COVID-19 vaccines have been quickly developed and deployed. Although minor adverse events, either local (e.g., soreness, itch, redness) or systematic (fever, malaise, headache, etc.), are not uncommon following any COVID-19 vaccination, one rare vaccine-associated event can cause fatal consequences due to development of antibodies against platelet factor 4 (PF4), which trigger platelet activation, aggregation, and possible resultant thrombosis, often at unusual vascular sites. Termed thrombosis with thrombocytopenia syndrome (TTS) by reporting government agencies, the term vaccine-induced (immune) thrombotic thrombocytopenia (VITT) is more widely adopted by workers in the field. In response to increasing reports of VITT, several expert groups have formulated guidelines for diagnosis and/or management of VITT. Herein, we review some key guidelines related to diagnosis of VITT, and also provide some commentary on their development and evolution. |
|---|---|
| AbstractList | Coronavirus disease 2019 (COVID-19) is a life-threatening infectious disease caused by Severe acute respiratory syndrome Coronavirus-2 (SARS-CoV-2). In response to the still ongoing pandemic outbreak, a number of COVID-19 vaccines have been quickly developed and deployed. Although minor adverse events, either local (e.g., soreness, itch, redness) or systematic (fever, malaise, headache, etc.), are not uncommon following any COVID-19 vaccination, one rare vaccine-associated event can cause fatal consequences due to development of antibodies against platelet factor 4 (PF4), which trigger platelet activation, aggregation, and possible resultant thrombosis, often at unusual vascular sites. Termed thrombosis with thrombocytopenia syndrome (TTS) by reporting government agencies, the term vaccine-induced (immune) thrombotic thrombocytopenia (VITT) is more widely adopted by workers in the field. In response to increasing reports of VITT, several expert groups have formulated guidelines for diagnosis and/or management of VITT. Herein, we review some key guidelines related to diagnosis of VITT, and also provide some commentary on their development and evolution. Coronavirus disease 2019 (COVID-19) is a life-threatening infectious disease caused by Severe acute respiratory syndrome Coronavirus-2 (SARS-CoV-2). In response to the still ongoing pandemic outbreak, a number of COVID-19 vaccines have been quickly developed and deployed. Although minor adverse events, either local (e.g., soreness, itch, redness) or systematic (fever, malaise, headache, etc.), are not uncommon following any COVID-19 vaccination, one rare vaccine-associated event can cause fatal consequences due to development of antibodies against platelet factor 4 (PF4), which trigger platelet activation, aggregation, and possible resultant thrombosis, often at unusual vascular sites. Termed thrombosis with thrombocytopenia syndrome (TTS) by reporting government agencies, the term vaccine-induced (immune) thrombotic thrombocytopenia (VITT) is more widely adopted by workers in the field. In response to increasing reports of VITT, several expert groups have formulated guidelines for diagnosis and/or management of VITT. Herein, we review some key guidelines related to diagnosis of VITT, and also provide some commentary on their development and evolution.Coronavirus disease 2019 (COVID-19) is a life-threatening infectious disease caused by Severe acute respiratory syndrome Coronavirus-2 (SARS-CoV-2). In response to the still ongoing pandemic outbreak, a number of COVID-19 vaccines have been quickly developed and deployed. Although minor adverse events, either local (e.g., soreness, itch, redness) or systematic (fever, malaise, headache, etc.), are not uncommon following any COVID-19 vaccination, one rare vaccine-associated event can cause fatal consequences due to development of antibodies against platelet factor 4 (PF4), which trigger platelet activation, aggregation, and possible resultant thrombosis, often at unusual vascular sites. Termed thrombosis with thrombocytopenia syndrome (TTS) by reporting government agencies, the term vaccine-induced (immune) thrombotic thrombocytopenia (VITT) is more widely adopted by workers in the field. In response to increasing reports of VITT, several expert groups have formulated guidelines for diagnosis and/or management of VITT. Herein, we review some key guidelines related to diagnosis of VITT, and also provide some commentary on their development and evolution. |
| Author | Favaloro, Emmanuel J Pasalic, Leonardo Lippi, Giuseppe |
| Author_xml | – sequence: 1 givenname: Emmanuel J orcidid: 0000-0002-2103-1661 surname: Favaloro fullname: Favaloro, Emmanuel J organization: Faculty of Science and Health, Charles Sturt University, Wagga Wagga, NSW, Australia – sequence: 2 givenname: Leonardo orcidid: 0000-0002-8237-6743 surname: Pasalic fullname: Pasalic, Leonardo organization: Sydney University, Westmead, NSW, Australia – sequence: 3 givenname: Giuseppe orcidid: 0000-0001-9523-9054 surname: Lippi fullname: Lippi, Giuseppe organization: Section of Clinical Biochemistry, University of Verona, Verona, Italy |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/34714985$$D View this record in MEDLINE/PubMed |
| BookMark | eNpNkMtLw0AYxBep2IdePcoe6yG6z6Q5Sn0VCgWpvYbN7rd1Jdmt2aTS_96ILQgDMzA_5jBjNPDBA0LXlNxRSeW91lWdMMJoQgnPz9CICp4lgnM6-JeHaBzjJyFUSpFdoCEXGRX5TI5QeIO9g2-svMGwD1XXuuBxsHjbOQOV8xCxDQ02Tm19iC7-dvPVZvGY0BzvldY9gp03nQaD248m1GVonT5FfWjDDrxTeLpZrNe3l-jcqirC1dEn6P35aT1_TZarl8X8YZloMSNtInLLreRWaA29WA5Sl8DAaKHBliqVimhKlaF5z2sKbEYhVcZyYtKZATZB07_dXRO-OohtUbuooaqUh9DFgsmcUJ5JkvbozRHtyhpMsWtcrZpDcTqJ_QDQz2z9 |
| CitedBy_id | crossref_primary_10_3390_v14081644 crossref_primary_10_3390_life12091338 crossref_primary_10_1055_s_0042_1742738 crossref_primary_10_1055_s_0042_1759736 crossref_primary_10_1097_APO_0000000000000519 crossref_primary_10_3389_fneur_2022_989730 crossref_primary_10_3389_fendo_2023_1111581 crossref_primary_10_1136_bcr_2022_254084 crossref_primary_10_1055_s_0044_1782197 crossref_primary_10_3390_antib11010007 crossref_primary_10_7326_M21_4502 crossref_primary_10_3390_vaccines9121473 crossref_primary_10_1055_s_0042_1759684 crossref_primary_10_1136_bmjopen_2021_059067 crossref_primary_10_1016_j_rpth_2024_102335 crossref_primary_10_1093_cid_ciac080 crossref_primary_10_3390_vaccines11020456 crossref_primary_10_1016_j_clinimag_2024_110338 crossref_primary_10_7774_cevr_2023_12_4_265 crossref_primary_10_1055_s_0044_1781450 crossref_primary_10_1080_14760584_2022_2116008 crossref_primary_10_1111_jth_15881 crossref_primary_10_3390_ijms232314715 crossref_primary_10_1055_a_2107_0891 crossref_primary_10_1016_j_annemergmed_2021_12_002 |
| ContentType | Journal Article |
| Copyright | 2021 Walter de Gruyter GmbH, Berlin/Boston. |
| Copyright_xml | – notice: 2021 Walter de Gruyter GmbH, Berlin/Boston. |
| DBID | CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1515/cclm-2021-1039 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| Discipline | Medicine Chemistry |
| EISSN | 1437-4331 |
| ExternalDocumentID | 34714985 |
| Genre | Journal Article Review |
| GroupedDBID | --- 0R~ 0~D 29B 354 36B 4.4 53G 5GY 5RE AAAEU AABBZ AAFPC AAGVJ AAILP AALGR AAOQK AAOWA AAPJK AAQCX AASQH AAWFC AAXCG ABAOT ABAQN ABFKT ABFQV ABIQR ABJNI ABLJU ABMIY ABPLS ABRDF ABUVI ABVMU ABWLS ABXMZ ABYBW ACDEB ACEFL ACGFS ACIWK ACPMA ACPRK ACZBO ADDWE ADEQT ADGQD ADGYE ADOZN AEDGQ AEGVQ AEICA AEJTT AENEX AEQDQ AERZL AEXIE AFBAA AFBQV AFCXV AFGDO AFQUK AFRAH AFYRI AGBEV AHOVO AHVWV AHXUK AIERV AJATJ AJHHK AKXKS ALMA_UNASSIGNED_HOLDINGS ALUKF ALYBR ASYPN BAKPI BBCWN BCIFA CGQUA CGR CS3 CUY CVF DBYYV DU5 EBS ECM EIF EMOBN F5P HZ~ IY9 KDIRW N9A NPM O9- OBC OBS OEB OES OHH P2P PQQKQ QD8 RDG SA. SLJYH TEORI UK5 WTRAM 7X8 AARRE ABDRH ACUND ACYCL ADNPR AECWL AFBDD AIWOI DSRVY |
| ID | FETCH-LOGICAL-c480t-49f3f53f4ccecce29e5cbe2edc4cefba65a0c11ad19480c1e281e6adf30d68de2 |
| IEDL.DBID | 7X8 |
| ISICitedReferencesCount | 30 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000727730300006&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1437-4331 |
| IngestDate | Thu Sep 04 17:32:47 EDT 2025 Wed Feb 19 02:28:30 EST 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | diagnosis thrombosis with thrombocytopenia syndrome (TTS) vaccine induced thrombotic thrombocytopenia (VITT) laboratory testing guideline |
| Language | English |
| License | 2021 Walter de Gruyter GmbH, Berlin/Boston. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c480t-49f3f53f4ccecce29e5cbe2edc4cefba65a0c11ad19480c1e281e6adf30d68de2 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 |
| ORCID | 0000-0002-2103-1661 0000-0002-8237-6743 0000-0001-9523-9054 |
| OpenAccessLink | https://www.degruyter.com/document/doi/10.1515/cclm-2021-1039/pdf?licenseType=free |
| PMID | 34714985 |
| PQID | 2590137506 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_2590137506 pubmed_primary_34714985 |
| PublicationCentury | 2000 |
| PublicationDate | 2022-01-01 |
| PublicationDateYYYYMMDD | 2022-01-01 |
| PublicationDate_xml | – month: 01 year: 2022 text: 2022-01-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | Germany |
| PublicationPlace_xml | – name: Germany |
| PublicationTitle | Clinical chemistry and laboratory medicine |
| PublicationTitleAlternate | Clin Chem Lab Med |
| PublicationYear | 2022 |
| SSID | ssj0015547 |
| Score | 2.4828198 |
| SecondaryResourceType | review_article |
| Snippet | Coronavirus disease 2019 (COVID-19) is a life-threatening infectious disease caused by Severe acute respiratory syndrome Coronavirus-2 (SARS-CoV-2). In... |
| SourceID | proquest pubmed |
| SourceType | Aggregation Database Index Database |
| StartPage | 7 |
| SubjectTerms | COVID-19 - prevention & control COVID-19 Vaccines - adverse effects Humans Thrombocytopenia - chemically induced Thrombocytopenia - diagnosis Thrombosis - chemically induced Thrombosis - diagnosis |
| Title | Review and evolution of guidelines for diagnosis of COVID-19 vaccine induced thrombotic thrombocytopenia (VITT) |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/34714985 https://www.proquest.com/docview/2590137506 |
| Volume | 60 |
| WOSCitedRecordID | wos000727730300006&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1JS8QwFA7qiHpxX8aNCB70UKbN0qYnkVHRg6OHUeZW0pdEBpxWnXHAf-9L28GbCF5KS5eUly95L2_JR8hppMJYcxyABpQIhJQQpNzipVDAnUq4hLAim0h6PTUYpI-Nw23cpFXO5sRqojYleB95h_kiSY76Lb54ew88a5SPrjYUGvOkxdGU8ahOBj9RBFSVFbmK4ElVGdRs2ogqvAPwOkKEMJ_PxX8xLys1c7P23x9cJ6uNgUkva0RskDlbbJLl7ozXbZMs3Tfh9C1S1pEBqgtD7bQBIS0dffn0u1_5jHiKRi01dT7ecOzvdR-e766CKKVTDf4zFFf1iA9DPePCKC-x3dkpfE08O9dQ07Pnu37_fJs83Vz3u7dBw8AQgFDhJBCp405yJwCwqy1LrYTcMmtAgHW5jqUOIYq0iVJ8HiLLVGRjbRwPTayMZTtkoSgLu-dTqBKjNC5gJDOCC8hlCImSSpsUopi5NjmZiTVDgfiwhS5s-TnOfgTbJrt132Rv9VYcGUfdKlIl9__w9gFZYb52ofKfHJKWw_Ftj8giTCfD8cdxBR089h7vvwH7IM73 |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Review+and+evolution+of+guidelines+for+diagnosis+of+COVID-19+vaccine+induced+thrombotic+thrombocytopenia+%28VITT%29&rft.jtitle=Clinical+chemistry+and+laboratory+medicine&rft.au=Favaloro%2C+Emmanuel+J&rft.au=Pasalic%2C+Leonardo&rft.au=Lippi%2C+Giuseppe&rft.date=2022-01-01&rft.eissn=1437-4331&rft.volume=60&rft.issue=1&rft.spage=7&rft_id=info:doi/10.1515%2Fcclm-2021-1039&rft_id=info%3Apmid%2F34714985&rft_id=info%3Apmid%2F34714985&rft.externalDocID=34714985 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1437-4331&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1437-4331&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1437-4331&client=summon |